Skip to content
DNDi Logo
  • DNDi INTERNATIONAL
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT DNDi
    • ABOUT DNDi NORTH AMERICA
    • OUR TEAM
    • BOARD OF DIRECTORS
    • OUR PUBLICATIONS
    • FINANCIALS
    • JOBS
    • Close
  • DISEASES & PROJECTS
  • ADVOCACY
  • MEDIA CENTER
  • DONATE
  • CONTACT
    • Close
  • Home

Media Center

RSS SCIENTIFIC ARTICLES

  • Identification of resistance determinants for a promising antileishmanial oxaborole series
  • Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: A prospective, multicentre, open-label, cohort study
  • A white-knuckle ride of open COVID drug discovery

RSS PRESS RELEASES

  • US FDA approves fexinidazole as the first all-oral treatment for sleeping sickness
  • Switzerland renews its commitment to DNDi’s mission
  • First hepatitis C treatment developed through South-South cooperation registered in Malaysia

RSS NEWS

RSS IN THE MEDIA

  • Avancées porteuses d’espoir en Indonésie pour éradiquer la dengue et l’hépatite C
  • Expertos alertan sobre la desatención global del Mal de Chagas
  • The Current with Matt Galloway – Interview with Dr Brenda Okware, Scientific Coordinator COVID-19 Clinical Research Coalition

RSS Scientific Articles

  • Identification of resistance determinants for a promising antileishmanial oxaborole series
  • Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: A prospective, multicentre, open-label, cohort study
  • A white-knuckle ride of open COVID drug discovery
  • How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Subscribe

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website

Donate

Support research for neglected disease treatments by making a gift

Authorize.net Seal

Charity Status

GuideStar Gold Participantnewyork-ac-seal-vertical-black-web

Social Mission Ratio

DNDi social mission ratio 2019

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close